The drug, lecanemab, was approved by Health Canada this week. It is the first treatment available in Canada to focus on the ...

Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Michael Borrie, physician and medical director of the Aging and Memory Clinic at St. Joseph’s Health Care London, said Health ...

A Kelowna woman who has been selling ivermectin online as a treatment for cancer has had her business raided by Health Canada ...

Ultragenyx sold some of its drug royalties for a treatment for rare bone disease to Omers Life Sciences for $400 million. The biopharmaceutical company said Tuesday the sale includes an additional 25% ...

In a Canadian Medical Association Journal (CMAJ) editorial published Monday, physicians Shannon Charlebois and Shawn Kelly ...

TORONTO — Health Canada has authorized a drug shown to slow the progression of Alzheimer’s disease. Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in ...

MONTREAL, Oct. /CNW/ – Today, AbbVie (NYSE: ABBV) has announced that Canada’s Drug Agency (CDA-AMC), formerly CADTH, has recommended that ELAHERE® (mirvetuximab soravtansine for ...

In an effort to fight growing drug addiction in Opaskwayak Cree Nation, the community wants to build a rehabilitation facility that will have movable interior walls to accommodate families of ...

Community advocates and health policy experts are raising questions and concerns about new involuntary treatment legislation ...

The Alzheimer Society of Ontario calls for immediate system investments to support access to the newly approved dementia treatment ...